Healthcare Industry NewsFeed
HSMN NewsFeed - 27 Jan 2016
BioPharmX Corporation Appoints Craig A. Barbarosh to its Board of Directors
BioPharmX Corporation Appoints Craig A. Barbarosh to its Board of Directors
HSMN NewsFeed - 27 Jan 2016
InnFocus MicroShunt(R) 3-Year Results of a Long Term Clinical Trial Show Long Lasting IOP Reduction
InnFocus MicroShunt(R) 3-Year Results of a Long Term Clinical Trial Show Long Lasting IOP Reduction
HSMN NewsFeed - 27 Jan 2016
Sotera(R) Wireless Surpasses 1 Million Hours Of Continuous Vital Signs Monitoring
Sotera(R) Wireless Surpasses 1 Million Hours Of Continuous Vital Signs Monitoring
HSMN NewsFeed - 26 Jan 2016
Surgical Specialties to Acquire Leading German Needle and Suture Manufacturer
Surgical Specialties to Acquire Leading German Needle and Suture Manufacturer
HSMN NewsFeed - 26 Jan 2016
Varian Medical Systems Appoints Dr. Patrick Kupelian VP of Clinical Affairs
Varian Medical Systems Appoints Dr. Patrick Kupelian VP of Clinical Affairs
HSMN NewsFeed - 26 Jan 2016
Abcodia Announces Expanded U.S. Availability of the ROCA(R) Test for Early Ovarian Cancer Detection
Abcodia Announces Expanded U.S. Availability of the ROCA(R) Test for Early Ovarian Cancer Detection
HSMN NewsFeed - 26 Jan 2016
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
HSMN NewsFeed - 25 Jan 2016
Opsens hires George Quinoy as Vice President / General Manager U.S. Commercial Sales & Operations
Opsens hires George Quinoy as Vice President / General Manager U.S. Commercial Sales & Operations
HSMN NewsFeed - 25 Jan 2016
Exact Sciences Announces Appointment of John A. Fallon, M.D., to Company's Board of Directors
Exact Sciences Announces Appointment of John A. Fallon, M.D., to Company's Board of Directors
HSMN NewsFeed - 25 Jan 2016
Amedica Enhances Valeo II(TM) Product Family With the Addition of Its Second Generation Cervical System
Amedica Enhances Valeo II(TM) Product Family With the Addition of Its Second Generation Cervical System
HSMN NewsFeed - 25 Jan 2016
Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis
Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis
HSMN NewsFeed - 25 Jan 2016
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
HSMN NewsFeed - 25 Jan 2016
Vertice Pharma appoints Dr. Indranil Nandi as Vice President, Research & Development
Vertice Pharma appoints Dr. Indranil Nandi as Vice President, Research & Development
HSMN NewsFeed - 25 Jan 2016
BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment
BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment
HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
HSMN NewsFeed - 22 Jan 2016
InspireMD Aligns Operations and Leadership Team, Appoints Isaac Blech as Vice Chairman of the Board
InspireMD Aligns Operations and Leadership Team, Appoints Isaac Blech as Vice Chairman of the Board
HSMN NewsFeed - 21 Jan 2016
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE(TM) Technology
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE(TM) Technology
HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
HSMN NewsFeed - 21 Jan 2016
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
HSMN NewsFeed - 20 Jan 2016
Monaghan Medical Introduces Manometer Adapter to Measure Treatment With Aerobika(R) OPEP Device
Monaghan Medical Introduces Manometer Adapter to Measure Treatment With Aerobika(R) OPEP Device
HSMN NewsFeed - 19 Jan 2016
Thetis Receives Orphan Drug Designation for TP-252 in Familial Adenomatous Polyposis
Thetis Receives Orphan Drug Designation for TP-252 in Familial Adenomatous Polyposis
HSMN NewsFeed - 19 Jan 2016
Amylyx Announces Election of Nobel Laureate Walter Gilbert, PhD, to Board of Directors
Amylyx Announces Election of Nobel Laureate Walter Gilbert, PhD, to Board of Directors
HSMN NewsFeed - 19 Jan 2016
ZipLine(R) Medical Secures $19 Million Financing Led by New Investor, MVM Life Science Partners LLP
ZipLine(R) Medical Secures $19 Million Financing Led by New Investor, MVM Life Science Partners LLP
HSMN NewsFeed - 19 Jan 2016
Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility
Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility
HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
HSMN NewsFeed - 18 Jan 2016
Michael Martino Named President and Chief Executive Officer of HemaFlo Therapeutics
Michael Martino Named President and Chief Executive Officer of HemaFlo Therapeutics
HSMN NewsFeed - 18 Jan 2016
LifeWatch Receives FDA Clearance for its Mobile Cardiac Telemetry 1-Lead Patch
LifeWatch Receives FDA Clearance for its Mobile Cardiac Telemetry 1-Lead Patch
HSMN NewsFeed - 17 Jan 2016
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
HSMN NewsFeed - 15 Jan 2016
Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve
Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve
HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
HSMN NewsFeed - 14 Jan 2016
Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events
Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events
HSMN NewsFeed - 14 Jan 2016
Imricor Medical Systems Receives CE Mark for MR Compatible Advantage-MR EP Recorder and Stimulator System
Imricor Medical Systems Receives CE Mark for MR Compatible Advantage-MR EP Recorder and Stimulator System
HSMN NewsFeed - 14 Jan 2016
Oculus Innovative Sciences Receives European CE Mark for New MucoClyns(TM) for First Responders
Oculus Innovative Sciences Receives European CE Mark for New MucoClyns(TM) for First Responders
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!